Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider Venom

Human accidents with spiders of the genus <i>Loxosceles</i> are an important health problem affecting thousands of people worldwide. Patients evolve to severe local injuries and, in many cases, to systemic disturbances as acute renal failure, in which cases antivenoms are considered to b...

Full description

Bibliographic Details
Main Authors: Paula A. L. Calabria, Lhiri Hanna A. L. Shimokawa-Falcão, Monica Colombini, Ana M. Moura-da-Silva, Katia C. Barbaro, Eliana L. Faquim-Mauro, Geraldo S. Magalhaes
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/11/2/108
_version_ 1798040513452965888
author Paula A. L. Calabria
Lhiri Hanna A. L. Shimokawa-Falcão
Monica Colombini
Ana M. Moura-da-Silva
Katia C. Barbaro
Eliana L. Faquim-Mauro
Geraldo S. Magalhaes
author_facet Paula A. L. Calabria
Lhiri Hanna A. L. Shimokawa-Falcão
Monica Colombini
Ana M. Moura-da-Silva
Katia C. Barbaro
Eliana L. Faquim-Mauro
Geraldo S. Magalhaes
author_sort Paula A. L. Calabria
collection DOAJ
description Human accidents with spiders of the genus <i>Loxosceles</i> are an important health problem affecting thousands of people worldwide. Patients evolve to severe local injuries and, in many cases, to systemic disturbances as acute renal failure, in which cases antivenoms are considered to be the most effective treatment. However, for antivenom production, the extraction of the venom used in the immunization process is laborious and the yield is very low. Thus, many groups have been exploring the use of recombinant <i>Loxosceles</i> toxins, particularly phospholipases D (PLDs), to produce the antivenom. Nonetheless, some important venom activities are not neutralized by anti-PLD antibodies. Astacin-like metalloproteases (ALMPs) are the second most expressed toxin acting on the extracellular matrix, indicating the importance of its inclusion in the antigen’s formulation to provide a better antivenom. Here we show the construction of a hybrid recombinant immunogen, called LgRec1ALP1, composed of hydrophilic regions of the PLD and the ALMP toxins from <i>Loxosceles gaucho</i>. Although the LgRec1ALP1 was expressed as inclusion bodies, it resulted in good yields and it was effective to produce neutralizing antibodies in mice. The antiserum neutralized fibrinogenolytic, platelet aggregation and dermonecrotic activities elicited by <i>L. gaucho</i>, <i>L. laeta</i>, and <i>L. intermedia</i> venoms, indicating that the hybrid recombinant antigen may be a valuable source for the production of protective antibodies against <i>Loxosceles</i> ssp. venoms. In addition, the hybrid recombinant toxin approach may enrich and expand the alternative antigens for antisera production for other venoms.
first_indexed 2024-04-11T22:08:42Z
format Article
id doaj.art-22360fea09084f66a9c7f059e143b31a
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-11T22:08:42Z
publishDate 2019-02-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-22360fea09084f66a9c7f059e143b31a2022-12-22T04:00:37ZengMDPI AGToxins2072-66512019-02-0111210810.3390/toxins11020108toxins11020108Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider VenomPaula A. L. Calabria0Lhiri Hanna A. L. Shimokawa-Falcão1Monica Colombini2Ana M. Moura-da-Silva3Katia C. Barbaro4Eliana L. Faquim-Mauro5Geraldo S. Magalhaes6Laboratory of Immunopathology, Butantan Institute, São Paulo 05503-900, BrazilLaboratory of Immunopathology, Butantan Institute, São Paulo 05503-900, BrazilLaboratory of Immunopathology, Butantan Institute, São Paulo 05503-900, BrazilLaboratory of Immunopathology, Butantan Institute, São Paulo 05503-900, BrazilLaboratory of Immunopathology, Butantan Institute, São Paulo 05503-900, BrazilLaboratory of Immunopathology, Butantan Institute, São Paulo 05503-900, BrazilLaboratory of Immunopathology, Butantan Institute, São Paulo 05503-900, BrazilHuman accidents with spiders of the genus <i>Loxosceles</i> are an important health problem affecting thousands of people worldwide. Patients evolve to severe local injuries and, in many cases, to systemic disturbances as acute renal failure, in which cases antivenoms are considered to be the most effective treatment. However, for antivenom production, the extraction of the venom used in the immunization process is laborious and the yield is very low. Thus, many groups have been exploring the use of recombinant <i>Loxosceles</i> toxins, particularly phospholipases D (PLDs), to produce the antivenom. Nonetheless, some important venom activities are not neutralized by anti-PLD antibodies. Astacin-like metalloproteases (ALMPs) are the second most expressed toxin acting on the extracellular matrix, indicating the importance of its inclusion in the antigen’s formulation to provide a better antivenom. Here we show the construction of a hybrid recombinant immunogen, called LgRec1ALP1, composed of hydrophilic regions of the PLD and the ALMP toxins from <i>Loxosceles gaucho</i>. Although the LgRec1ALP1 was expressed as inclusion bodies, it resulted in good yields and it was effective to produce neutralizing antibodies in mice. The antiserum neutralized fibrinogenolytic, platelet aggregation and dermonecrotic activities elicited by <i>L. gaucho</i>, <i>L. laeta</i>, and <i>L. intermedia</i> venoms, indicating that the hybrid recombinant antigen may be a valuable source for the production of protective antibodies against <i>Loxosceles</i> ssp. venoms. In addition, the hybrid recombinant toxin approach may enrich and expand the alternative antigens for antisera production for other venoms.https://www.mdpi.com/2072-6651/11/2/108phospholipases Dmetalloproteases<i>Loxosceles</i> spp.recombinant toxinshybrid immunogenneutralizing antibodiesantivenoms
spellingShingle Paula A. L. Calabria
Lhiri Hanna A. L. Shimokawa-Falcão
Monica Colombini
Ana M. Moura-da-Silva
Katia C. Barbaro
Eliana L. Faquim-Mauro
Geraldo S. Magalhaes
Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider Venom
Toxins
phospholipases D
metalloproteases
<i>Loxosceles</i> spp.
recombinant toxins
hybrid immunogen
neutralizing antibodies
antivenoms
title Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider Venom
title_full Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider Venom
title_fullStr Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider Venom
title_full_unstemmed Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider Venom
title_short Design and Production of a Recombinant Hybrid Toxin to Raise Protective Antibodies against <em>Loxosceles</em> Spider Venom
title_sort design and production of a recombinant hybrid toxin to raise protective antibodies against em loxosceles em spider venom
topic phospholipases D
metalloproteases
<i>Loxosceles</i> spp.
recombinant toxins
hybrid immunogen
neutralizing antibodies
antivenoms
url https://www.mdpi.com/2072-6651/11/2/108
work_keys_str_mv AT paulaalcalabria designandproductionofarecombinanthybridtoxintoraiseprotectiveantibodiesagainstemloxoscelesemspidervenom
AT lhirihannaalshimokawafalcao designandproductionofarecombinanthybridtoxintoraiseprotectiveantibodiesagainstemloxoscelesemspidervenom
AT monicacolombini designandproductionofarecombinanthybridtoxintoraiseprotectiveantibodiesagainstemloxoscelesemspidervenom
AT anammouradasilva designandproductionofarecombinanthybridtoxintoraiseprotectiveantibodiesagainstemloxoscelesemspidervenom
AT katiacbarbaro designandproductionofarecombinanthybridtoxintoraiseprotectiveantibodiesagainstemloxoscelesemspidervenom
AT elianalfaquimmauro designandproductionofarecombinanthybridtoxintoraiseprotectiveantibodiesagainstemloxoscelesemspidervenom
AT geraldosmagalhaes designandproductionofarecombinanthybridtoxintoraiseprotectiveantibodiesagainstemloxoscelesemspidervenom